Viewing Study NCT03937895

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 1:17 PM

Ignite Modification Date: 2025-12-27 @ 9:14 PM

Study NCT ID: NCT03937895

Status: COMPLETED

Last Update Posted: 2022-03-29

First Post: 2019-04-29

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Allogeneic NK Cell ("SMT-NK") in Combination With Pembrolizumab in Advanced Biliary Tract Cancer

Sponsor: SMT bio Co., Ltd.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module